Targeting intracranial patient-derived glioblastoma (GBM) with a NIR-I fluorescent immunoconjugate for facilitating its image-guided resection
Keyword(s):
Fluorescent immunoconjugate cetuximab-IRDye800 bypasses the blood-brain-barrier to afford visualization of patient-derived GBM39 brain tumor tissue for facilitating its fluorescence-guided resection.
Keyword(s):
2012 ◽
Vol 111
(2)
◽
pp. 133-143
◽
Keyword(s):
2014 ◽
Vol 32
(3)
◽
pp. 1072-1083
◽
Keyword(s):
2015 ◽
Vol 355
(2)
◽
pp. 264-271
◽
Keyword(s):
1995 ◽
Vol 54
(3)
◽
pp. 441
Keyword(s):
Keyword(s):